GNMLF.US Genomma Lab Internacional S.A.B. de C.V

Healthcare Pharmaceuticals USA Stocks
0.8500 USD
Close of Nov 14, 2026
0.6850 1.05
Market cap
USD 831M
P/E
8.5x
P/B
1.27x
ROE
14.6%
Dividend yield
5.21%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is GNMLF.US undervalued?

Graham number
Price0.8500
Graham value1.23
Discount30.9%

GNMLF.US trades 30.9% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Genomma Lab Internacional S.A.B. de C.V fundamental analysis

No fundamental analysis for Genomma Lab Internacional S.A.B. de C.V yet.

Genomma Lab Internacional S.A.B. de C.V stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Genomma Lab Internacional S.A.B. de C.V

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the re…

Full company profile